Skip to main content
Clinical Trials/NCT05534100
NCT05534100
Terminated
Not Applicable

Using Wearable Technology to Detect Symptoms of Posttraumatic Stress Disorder

Rush University Medical Center1 site in 1 country14 target enrollmentNovember 1, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Posttraumatic Stress Disorder
Sponsor
Rush University Medical Center
Enrollment
14
Locations
1
Primary Endpoint
Clinician Administered PTSD Scale for DSM-5
Status
Terminated
Last Updated
2 years ago

Overview

Brief Summary

The aim of the project is to advance our understanding of how individuals with Posttraumatic Stress Disorder (PTSD) experience symptoms in their every-day lives when they are in their home environment. To date, all PTSD assessments are retrospective; individuals with PTSD are asked to recount and report their symptoms over the past weeks or months. Such assessment procedures are negatively impacted by individuals' abilities to accurately recall information. Moreover, retrospective assessments provide little information about how symptoms are experienced in the moment and how these experiences then lead to other behaviors. The proposed project addresses these limitations by assessing PTSD symptoms and associated biological markers (e.g., sleep, heart rate, heart rate variability) in real-time by asking subjects to wear a smart device and complete brief surveys. Data will be collected from 50 individuals with PTSD and 20 healthy controls to help us better understand individuals' real-time experience with PTSD and lay the foundation to develop algorithms for possible in-the-moment interventions in the future.

Registry
clinicaltrials.gov
Start Date
November 1, 2022
End Date
September 1, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Philip Held

Research Director

Rush University Medical Center

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Clinician Administered PTSD Scale for DSM-5

Time Frame: Through study completion, average of 1 month

Clinician administered measure of PTSD

PTSD Checklist for DSM-5 Criteria

Time Frame: Through study completion, average of 1 month

Self-report measure of PTSD

Study Sites (1)

Loading locations...

Similar Trials